Entrada Therapeutics Ownership | Who Owns Entrada Therapeutics?
Entrada Therapeutics Ownership Summary
Entrada Therapeutics is owned by 7.45% institutional investors, 12.31% insiders, and 80.24% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 12.26% of TRDA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 4.01% of its assets in Entrada Therapeutics shares.
TRDA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Entrada Therapeutics | 7.45% | 12.31% | 80.24% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 5.07M | 12.26% | $64.02M |
| Mpm asset management | 4.38M | 10.60% | $25.41M |
| 5am venture management | 4.06M | 9.80% | $51.19M |
| Blackrock funding, inc. /de | 2.36M | 5.70% | $29.77M |
| Tcg crossover management | 2.29M | 5.53% | $28.87M |
| Janus henderson group | 2.08M | 5.12% | $36.01M |
| Blackrock | 1.69M | 5.06% | $24.14M |
| Vanguard group | 1.63M | 3.94% | $16.78M |
| Wellington management group llp | 1.03M | 2.50% | $13.06M |
| Stepstone group lp | 761.28K | 1.84% | $9.61M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mpm asset management | 4.38M | 57.09% | $25.41M |
| 5am venture management | 4.06M | 14.21% | $51.19M |
| Stepstone group lp | 761.28K | 4.63% | $9.61M |
| Tcg crossover management | 2.29M | 0.83% | $28.87M |
| Acuta capital partners | 89.36K | 0.80% | $1.13M |
| Corton capital | 38.85K | 0.55% | $225.32K |
| Nan fung group | 49.08K | 0.51% | $619.41K |
| Lynx1 capital management lp | 211.69K | 0.42% | $2.67M |
| Baker bros. advisors lp | 5.07M | 0.37% | $64.02M |
| Longaeva partners | 204.98K | 0.10% | $2.59M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 2.08M | 0.02% | 368.91K |
| Blackrock funding, inc. /de | 2.36M | 0.00% | 211.53K |
| Blackrock | 1.69M | 0.00% | 207.70K |
| Longaeva partners | 204.98K | 0.10% | 204.98K |
| Tcg crossover management | 2.29M | 0.83% | 199.11K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Redmile group | - | - | -560.97K |
| Algert global | - | - | -128.61K |
| Royce & associates lp | 120.84K | 0.02% | -126.30K |
| Sphera funds management | - | - | -110.94K |
| Arrowstreet capital, limited partnership | - | - | -102.01K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Longaeva partners | 204.98K | 0.10% | 204.98K | $2.59M |
| Nantahala capital management | 159.33K | 0.07% | 159.33K | $2.01M |
| Vanguard fiduciary trust | 156.86K | 0.00% | 156.86K | $1.98M |
| Cubist systematic strategies | 122.68K | 0.00% | 122.68K | $711.52K |
| Acuta capital partners | 89.36K | 0.80% | 89.36K | $1.13M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Amundi | -12.00 |
| Parallel advisors | -16.00 |
| Advantage alpha capital partners lp | -20.00 |
| C m bidwell & associates | -29.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 43 | -62.28% | 3,082,918 | -87.38% | 7 | 0.21% | 27 | -46.00% | 6 | -85.71% |
| Dec 31, 2025 | 62 | -47.01% | 7,762,092 | -72.74% | 18 | 0.39% | 24 | -68.00% | 24 | -11.11% |
| Sep 30, 2025 | 62 | -38.00% | 8,507,595 | -70.84% | 20 | 0.41% | 35 | -44.44% | 20 | -4.76% |
| Jun 30, 2025 | 105 | -4.55% | 29,576,026 | 37.87% | 71 | 2.62% | 66 | 37.50% | 23 | -45.24% |
| Mar 31, 2025 | 110 | 5.77% | 30,175,230 | -1.40% | 73 | 1.29% | 46 | -25.81% | 42 | 82.61% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 1.52M | 4.01% | -163.10K |
| T. Rowe Price New Horizons | 1.37M | 3.59% | -157.39K |
| Vanguard Total Stock Mkt Idx Inv | 953.73K | 2.46% | - |
| iShares Russell 2000 ETF | 676.29K | 1.74% | 5.69K |
| Fidelity Growth Compy Commingled Pl O | 561.18K | 1.51% | - |
| T. Rowe Price New Horizons Tr-A | 459.17K | 1.21% | 7.79K |
| T. Rowe Price New Horizons Tr-Z | 451.38K | 1.20% | 649.00 |
| T. Rowe Price Health Sciences | 329.23K | 0.86% | 171.51K |
| Vanguard Institutional Extnd Mkt Idx Tr | 283.54K | 0.73% | 10.09K |
| Fidelity Small Cap Index | 277.43K | 0.71% | 2.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 20, 2026 | Zeiher Bernhardt G | - | Buy | $29.32K |
| May 04, 2026 | Sethuraman Natarajan | President, Research & Develop. | Sell | $398.81K |
| May 04, 2026 | Dowden Nathan J | President & COO | Sell | $229.95K |
| Apr 01, 2026 | WENTWORTH KORY JAMES | Chief Financial Officer | Sell | $32.38K |
| Mar 09, 2026 | Dowden Nathan J | President & COO | Sell | $40.58K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 1 | 3 |
| 2026 Q1 | - | 5 |
| 2025 Q4 | 16 | 3 |
| 2025 Q3 | - | 8 |
| 2025 Q2 | - | 8 |
TRDA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools